- £14.80bn
- £16.59bn
- £6.12bn
- 84
- 28
- 91
- 81
Annual income statement for Next, fiscal year end - January 25th, GBP millions except per share, conversion factor applied.
2021 January 30th | 2022 January 29th | 2023 January 28th | 2024 January 27th | 2025 January 25th | |
---|---|---|---|---|---|
Period Length: | 53 W | 52 W | 52 W | 52 W | 52 W |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,534 | 4,626 | 5,034 | 5,491 | 6,118 |
Cost of Revenue | |||||
Gross Profit | 1,303 | 2,001 | 2,206 | 2,457 | 2,662 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,090 | 3,721 | 4,093 | 4,395 | 5,043 |
Operating Profit | 445 | 905 | 942 | 1,097 | 1,075 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 342 | 823 | 869 | 1,016 | 987 |
Provision for Income Taxes | |||||
Net Income After Taxes | 287 | 678 | 711 | 801 | 743 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 287 | 678 | 712 | 802 | 736 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 287 | 678 | 712 | 802 | 736 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.3 | 5.84 | 6.96 | 6.62 | 7.16 |
Dividends per Share | |||||
Special Dividends per Share |